PUTNAM INVESTMENTS LLC - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 29 filers reported holding TRILLIUM THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
PUTNAM INVESTMENTS LLC ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$470,000
-68.2%
83,111
-16.9%
0.00%
-75.0%
Q3 2016$1,478,000
+64.6%
100,0000.0%0.00%
+100.0%
Q2 2016$898,000
-2.9%
100,0000.0%0.00%0.0%
Q1 2016$925,000
-26.6%
100,0000.0%0.00%
-33.3%
Q4 2015$1,261,000
-3.2%
100,0000.0%0.00%0.0%
Q3 2015$1,303,000
-40.3%
100,0000.0%0.00%
-25.0%
Q2 2015$2,182,000100,0000.00%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q4 2015
NameSharesValueWeighting ↓
VR Adviser, LLC 4,040,000$59,428,0008.74%
Fairmount Funds Management LLC 1,478,181$21,744,0007.78%
COMMODORE CAPITAL LP 852,871$12,546,0006.82%
Ghost Tree Capital, LLC 1,950,000$28,685,0006.39%
Endurant Capital Management LP 655,741$9,646,0003.48%
FRAZIER MANAGEMENT LLC 3,053,107$44,879,0003.46%
ACUTA CAPITAL PARTNERS, LLC 803,000$11,812,0003.21%
NEA Management Company, LLC 5,736,363$84,382,0002.23%
Tri Locum Partners LP 296,838$4,366,0001.59%
Avidity Partners Management LP 3,185,200$46,854,0001.52%
View complete list of TRILLIUM THERAPEUTICS INC shareholders